About: BrainsWay Ltd. develops and sells noninvasive neurostimulation treatments for mental health disorders in the United States and internationally. It offers Deep Transcranial Magnetic Stimulation platform technology for the treatment of major depressive disorders, anxious and late-life depression, obsessive-compulsive disorders, smoking addiction, bipolar disorders, post-traumatic stress disorders, schizophrenia, Alzheimer's disease, autism, chronic pain, multiple sclerosis, post stroke rehabilitation, and Parkinson's diseases. The company serves doctors, hospitals, and medical centers in the field of psychiatry. The company was founded in 2003 and is headquartered in Jerusalem, Israel.
Sector: Healthcare
Industry: Medical Devices
Latest price: $11.93 (+4.93%)
BWAY NASDAQ Brainsway Ltd
Brainsway Ltd share price
Atividade de preço de BWAY
Último preço
$ 11,930
Variação (24h)
0,56 USD (4,93%)
Volume
120.35K
Volume (média 4 sem.)
-
Abertura
$ 11,85
Variação do dia
$ 11,59 - $ 12,05
Fechamento anterior
$ 11,37
Último negócio
29 Oct, 8:00 pm GMT+0
Atrasado
29 Oct, 8:00 pm GMT+0
BWAY price performance
Atrasado
29 Oct, 8:00 pm GMT+0
quote.marketSignals